• Cholecystokinin Octapeptide Ammonium: Immunomodulation and M

  2026-05-09

  Explore the immunoregulatory mechanisms and advanced applications of Cholecystokinin octapeptide ammonium (CCK-8 ammonium). This article uniquely analyzes its role in B cell modulation and assay design, offering technical guidance for researchers.

• Aconitase Activity Colorimetric Assay Kit: Precision in TCA

  2026-05-08

  The Aconitase Activity Colorimetric Assay Kit empowers researchers to quantify mitochondrial aconitase activity with high sensitivity and rapid turnaround. Its robust design supports oxidative damage measurement and high-throughput workflows, providing actionable insights into immunometabolic dynamics and TCA cycle function.

• MK-4827 (Niraparib): Protocol Innovations for DNA Repair Stu

  2026-05-08

  MK-4827 (Niraparib) enables precise inhibition of DNA repair, with optimized workflows now extending its utility beyond BRCA-mutant models. Recent evidence demonstrates that hyperthermia can sensitize resistant ovarian cancer cells to PARP inhibition, unlocking new avenues for combinatorial therapy development.

• WEHI-539: Precision BCL-XL Inhibition for Apoptosis Research

  2026-05-07

  WEHI-539 stands out as a selective, potent BCL-XL inhibitor that enables precise dissection of apoptotic resistance in cancer and stem cell models. This guide details advanced workflows, troubleshooting strategies, and new insights from recent synthetic lethality research, empowering researchers to maximize assay reproducibility and translational impact.

• Spectrophotometric Quantification of Alfuzosin HCl in Binary

  2026-05-07

  This study introduces the first validated spectrophotometric methods for quantifying Alfuzosin HCl and tadalafil in their combined pharmaceutical formulations. By resolving overlapping UV spectra using absorbance subtraction and ratio difference mathematical techniques, the work enables accurate, affordable, and green analysis critical for benign prostatic hyperplasia (BPH) research and formulation quality control.

• Disrupting SARS-CoV-2 Nucleocapsid Phase Separation: Mechani

  2026-05-06

  This study establishes that the SARS-CoV-2 nucleocapsid (N) protein undergoes RNA-triggered liquid–liquid phase separation (LLPS), a process critical for viral replication. It further identifies (-)-gallocatechin gallate (GCG) as a direct inhibitor of N protein LLPS and viral replication, highlighting a new molecular target for antiviral strategies.

• Deferasirox: Oral Iron Chelator Workflows in Cancer Research

  2026-05-06

  Deferasirox stands out as a versatile oral iron chelator for both iron overload and cancer research, enabling precise modulation of iron metabolism and cellular stress pathways. This guide reveals advanced experimental strategies, troubleshooting tactics, and protocol optimizations to maximize reproducibility and data quality when using Deferasirox from APExBIO.

• H-89: Selective cAMP-Dependent Protein Kinase Inhibitor

  2026-05-05

  H-89 is a potent, selective cAMP-dependent protein kinase inhibitor with an IC50 of 48 nM. It is widely used to dissect cAMP signaling pathways and interrogate PKA function in cellular and metabolic assays. Its specificity and well-characterized profile make it a benchmark tool for applications in apoptosis, cell proliferation, and osteogenic research.

• Cleavage-Resistant TREM2 Enhances Macrophage Efferocytosis i

  2026-05-05

  Dong et al. present a synthetic cleavage-resistant TREM2 receptor (CRT) that resists ADAM17-mediated shedding, thereby restoring and amplifying macrophage efferocytosis under inflammatory conditions. Their engineered mRNA-LNP platform enables in situ generation of CRT-expressing macrophages, which effectively reduce inflammatory burden in mouse models of steatohepatitis and atherosclerosis.

• Oteseconazole (VT-1161): Advanced Antifungal Assays for Cand

  2026-05-04

  Oteseconazole (VT-1161) is redefining antifungal research with its unmatched selectivity and potency against Candida, especially fluconazole-resistant strains. This article delivers actionable assay protocols, troubleshooting guidance, and key innovations from recent breakthroughs, empowering researchers to streamline workflows and generate reliable, translational data.

• AZD-3463: Next-Gen ALK/IGF1R Inhibition for Translational Ca

  2026-05-04

  Explore the advanced applications of AZD3463, a potent ALK/IGF1R inhibitor, in translational neuroblastoma research. This article uniquely bridges molecular mechanism with assay design, highlighting evidence-driven guidance and practical workflow insights.

• Necrostatin 2 (Nec-2): Optimizing Necroptosis Inhibition Wor

  2026-05-03

  Necrostatin 2 (Nec-2) empowers researchers with nanomolar precision for dissecting necroptosis, particularly in models where apoptosis is inhibited. This guide translates cutting-edge membrane biology findings into actionable protocols, troubleshooting, and advanced applications for cell death pathway research.

• Dual-Action Inhibitors Accelerate p38α MAPK Dephosphorylatio

  2026-05-02

  This study reveals that select kinase inhibitors not only block p38α MAP kinase activity but also promote its dephosphorylation by stabilizing a conformation accessible to phosphatases. These findings have direct implications for optimizing inhibitor design and improving specificity in inflammatory disease research.

• Reliable NADH (Reduced-form Nicotinamide Adenine Dinucleotid

  2026-05-02

  This article addresses persistent laboratory challenges in cell viability and mitochondrial research, illustrating how NADH (Reduced-form Nicotinamide Adenine Dinucleotide) CAS No. 58-68-4 (SKU C8749) directly improves assay reproducibility, redox sensitivity, and workflow robustness. Evidence-based Q&A scenarios guide researchers in protocol optimization, data interpretation, and informed product selection, positioning APExBIO’s NADH as a validated resource for rigorous biomedical experimentation.

• Vancomycin Hydrochloride in Applied Resistance Assays

  2026-05-01

  Vancomycin hydrochloride stands as a benchmark glycopeptide antibacterial agent, enabling rigorous antibiotic resistance profiling and Gram-positive bacteria inhibition in both in vitro and in vivo models. This article delivers actionable workflow enhancements, troubleshooting insights, and comparative context grounded in the latest research and referenced experimental protocols.

16335 records 1/1089 page Next 12345 下5页 Last page